SCHEMBL4749525

SCHEMBL4749525

O=CC(c1ccc(Br)cc1)c1cccc(C(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.46
ACP3 P15309 3/20 0.42
PNMT P11086 1/20 0.42
LMNA P02545 2/20 0.42
GAA P10253 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
IGF1R P08069 1/20 0.41
IDO1 P14902 1/20 0.40
TDO2 P48775 1/20 0.40
DAO P14920 1/20 0.38
SLC6A4 P31645 2/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
HTR6 P50406 1/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
RECQL P46063 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6970288 0.89 ACP3 (0.50) CES2ACP3PNMTIDO1TDO2
SCHEMBL5185325 0.87 ACP3 (0.54) CES2ACP3PNMTLMNAIDO1
SCHEMBL17593410 0.86 CES2 (0.47) CES2ACP3PNMTLMNAGAA
SCHEMBL7555691 0.82 CES2 (0.46) CES2ACP3PNMTIDO1TDO2
SCHEMBL3905843 0.81 CES2 (0.44) CES2ACP3PNMTIDO1TDO2
SCHEMBL11050404 0.81 MAOB (0.47) CES2ACP3LMNAGAAIDO1
SCHEMBL5990120 0.81 CES2 (0.43) CES2ACP3PNMTIDO1TDO2
SCHEMBL7861158 0.80 HDAC4 (0.42) CES2IDO1TDO2SLC6A4MAPT
SCHEMBL9602349 0.77 KIF11 (0.48) CES2ACP3PNMTGAAMEN1
SCHEMBL1515746 0.76 HTR2A (0.50) LMNASLC6A4MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008123821-A1 4, 5-DIHYDRO-LH-IMIDAZOL-2-AMINE DERIVATIVES FOR USE IN THE TREATMENT OF RESPIRATORY, CARDIOVASCULAR, NEUROLOGICAL OR GASTROINTESTINAL DISORDERS ALBIREO AB (SE) 2008-10-16 WO disclosed